INS and metabolic syndrome: Ath+HFD induces dyslipidemia, lipid peroxidation, and stellate cell activation in the liver and finally causes precirrhotic steatohepatitis after 24 weeks accompanied by cellular ballooning and hepatic insulin resistance.19